QQ客服 官方微博 反馈留言

	Efficacy and safety of targeted therapy for metastatic HER2-positive breast cancer in the first-line treatment: a Bayesian network meta-analysis
	Feng, Fubin; Zhang, Tingting; Yin, Fang; Liu, Cun; Zhuang, Jing; Qi, Lingyu; Wang, Xue; Li, Jia; Wang, Lu; Tian, Jinhui
刊名	ONCOTARGETS AND THERAPY
	2019
卷号	12页码:959-974
关键词	breast cancer metastasis HER2-positive HER2-targeted agents network meta-analysis randomized controlled trial
DOI	10.2147/OTT.S187739
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4541928
专题	山东大学
作者单位	Weifang Tradit Chinese Hosp, Dept Oncol, 1055 Weizhou Rd, Weifang, Shandong, Peoples R China.
推荐引用方式 GB/T 7714	Feng, Fubin,Zhang, Tingting,Yin, Fang,et al. Efficacy and safety of targeted therapy for metastatic HER2-positive breast cancer in the first-line treatment: a Bayesian network meta-analysis[J]. ONCOTARGETS AND THERAPY,2019,12:959-974.
APA	Feng, Fubin.,Zhang, Tingting.,Yin, Fang.,Liu, Cun.,Zhuang, Jing.,...&Sun, Chan 更多.(2019).Efficacy and safety of targeted therapy for metastatic HER2-positive breast cancer in the first-line treatment: a Bayesian network meta-analysis.ONCOTARGETS AND THERAPY,12,959-974.
MLA	Feng, Fubin,et al."Efficacy and safety of targeted therapy for metastatic HER2-positive breast cancer in the first-line treatment: a Bayesian network meta-analysis".ONCOTARGETS AND THERAPY 12(2019):959-974.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。